Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others


Johann Gudjonsson, MD, PhD
University of Michigan
Ann Arbor, Michigan, United States
IPC Board Member

Dr. Gudjonsson is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute and an Associate Prof. and Director of Inpatient Consultation and Dermatology at the University of Michigan, Ann Arbor.

Last Updated: Sep 18, 2018

Nicole L. Ward, PhD
Case Western Reserve University
Cleveland, Ohio, United States

Dr. Ward is an Associate Prof. of Dermatology and Director of the Morphology Core of the Skin Diseases Research Center in the Department of Dermatology at Case Western Reserve University and University Hospitals Case Medical Center. As a researcher, Dr. Ward has obtained national and international research funding. Her work has primarily focused on three unique, but overlapping, conceptual areas in psoriasis pathogenesis. They are: 1) skin inflammation drives remote vascular inflammation and thrombosis, 2) the neural activation of skin inflammation and proliferation, and 3) elucidating a role for Il-17c and IL-17RE signaling in psoriasis pathogenesis. Dr. Ward has been first or senior author on more than 50 publications and has been invited as a plenary speaker at national and international meetings.

Last Updated: Jan 26, 2018


Vinod Chandran, MBBS, MD, DM, PhD
University of Toronto
Toronto, Ontario, Canada

Vinod Chandran MBBS MD DM PhD, a Rheumatologist and clinician-scientist, is an Associate Professor of Medicine & Laboratory Medicine and Pathobiology at the University of Toronto, an Adjunct Professor at the Memorial University of Newfoundland, an affiliate scientist at the Krembil Research Institute, a member of the graduate faculty at the Institute of Medical Science, University of Toronto, a scientist with the Creative Destruction Lab, Rotman School of Management, University of Toronto and a staff physician at the University Health Network and Mount Sinai Hospitals. He co-directs the Psoriatic Disease Program at the University Health Network, Toronto, Canada.

Dr. Chandran’s research interests lie in the genetic and molecular epidemiology of psoriasis and psoriatic arthritis, especially with regard to prognosis. His translational research program is focused on developing proteomics and metabolomics-based screening and prognostic tools for psoriatic arthritis. His bench research aims to identify mechanisms underlying inflammation and joint damage in psoriatic arthritis, and developing novel topical and systemic anti- psoriatic therapies. He is also investigating the cutaneous microbiome in psoriasis and PsA and its relationship to psoriatic disease phenotype and genotype. He is a member of the executive committee of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. He is an active collaborator in multi-centre research consortia such as the International Psoriasis and Arthritis Research Team and the Spondyloarthritis Research Consortium of Canada and aims to conduct validation studies of discoveries made at his program through these collaborations.

Last Updated: Mar 06, 2020

We use cookies on this website to enhance your experience. By continuing with this website, you consent to our use of cookies. Learn more.